{"id":546150,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2014-08-22] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-10","captureTimestamp":"2026-03-10T22:53:01.936000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-5.html","snippet":"Notice: Prescription Drug List (PDL): Multiple additions August 22, 2014 Our file number: 14-110337-38 The purpose of this Notice of Amendment is to notify the addition of Bosutinib, Eslicarbasepine acetate, Icatibant acetate, Oclacitinib maleate, Elosulfase alfa, and Afoxolaner…","rawSnapshotUrl":"/api/snapshots/raw/546150","browseUrl":"https://replay.healtharchive.ca/job-6/20260310225301/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-5.html#ha_snapshot=546150","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}